Tervonen, Hanna E <br/><br/>
Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.  [electronic resource] 

 -  Pharmacoepidemiology and drug safety  06 2019 
 - 812-820 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1557 
<br/><br/><label>Standard No.: </label>10.1002/pds.4751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Anastrozole--therapeutic use<br/>Antineoplastic Agents, Hormonal--standards<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--standards<br/>Aromatase Inhibitors--therapeutic use<br/>Australia--epidemiology<br/>Breast Neoplasms--drug therapy<br/>Duration of Therapy<br/>Evidence-Based Medicine--standards<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasm Staging<br/>Practice Guidelines as Topic<br/>Practice Patterns, Physicians'--standards<br/>Professional Practice Gaps--statistics & numerical data<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Retrospective Studies<br/>Tamoxifen--therapeutic use<br/>Time Factors<br/>Trastuzumab--therapeutic use<br/>Assessment of Medication Adherence